Drug Search Results

Teneligliptin

Alternative Names: teneligliptin, mp-513, mp513, mp 513
Latest Update: 2024-06-18
Latest Update Note: News Article

Product Description

Mechanisms of Action: DPP4 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Mitsubishi Tanabe
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Teneligliptin

Countries in Clinic: Korea

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Type 2 Diabetes

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
TERA 304	P3	Recruiting	Type 2 Diabetes	2024-11-01
TERA 305	P3	Recruiting	Type 2 Diabetes	2024-11-01

Recent News Events

Date	Type	Title
06/18/2024	News Article	Endocrinology Drugs Market size is set to grow by USD 36.83 billion from 2024-2028, increase in incidence of endocrine disorders to boost the market growth, Technavio
05/10/2024	PubMed	Reductive N-Alkylation of Amines with Ketones Using Heterogeneous Polysilane-Palladium Catalysts under Continuous-Flow Conditions.
04/15/2024	PubMed	Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome.
03/01/2024	PubMed	Evaluation of microalbuminuria in type-2 diabetes mellitus under oral hypoglycemic agents: Association with age, sex, BMI, and renal clearance.
05/22/2023	News Article	Diabetes Drugs Market Size to Worth Around USD 118 BN by 2032

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions